Leuko Labs
Year
2019
Area
Devices and Materials, Healthcare and Medical
Leuko Labs’ technology monitors white blood cell levels non-invasively, helping immunosuppressed and chemotherapy patients avoid infections and febrile neutropenia.
Shining light into the skin surrounding the fingernail, Leuko’s device images the blood cells flowing through superficial capillaries to determine if white cell levels are dangerously low. There is no need to extract blood. Millions of immunosuppressed patients can now be tested more frequently, improving their quality of life and clinical outcomes.
A new way to spot life-threatening infections in cancer patients
Leuko is giving doctors a noninvasive way to monitor health during chemotherapy — no blood tests needed
Non-invasive white cell count prototype
The company is a spin-out from the 2016 project, Non-invasive white cell count prototype.